PL2129386T3 - Probiotyki do zmniejszania ryzyka występowania otyłości - Google Patents

Probiotyki do zmniejszania ryzyka występowania otyłości

Info

Publication number
PL2129386T3
PL2129386T3 PL08716883T PL08716883T PL2129386T3 PL 2129386 T3 PL2129386 T3 PL 2129386T3 PL 08716883 T PL08716883 T PL 08716883T PL 08716883 T PL08716883 T PL 08716883T PL 2129386 T3 PL2129386 T3 PL 2129386T3
Authority
PL
Poland
Prior art keywords
probiotics
obesity
risk
reduction
Prior art date
Application number
PL08716883T
Other languages
English (en)
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38330170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2129386(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL2129386T3 publication Critical patent/PL2129386T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08716883T 2007-03-28 2008-02-15 Probiotyki do zmniejszania ryzyka występowania otyłości PL2129386T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105072A EP1974734A1 (en) 2007-03-28 2007-03-28 Probiotics for reduction of risk of obesity
PCT/EP2008/051877 WO2008116700A1 (en) 2007-03-28 2008-02-15 Probiotics for reduction of risk of obesity
EP08716883.7A EP2129386B2 (en) 2007-03-28 2008-02-15 Probiotics for reduction of risk of obesity

Publications (1)

Publication Number Publication Date
PL2129386T3 true PL2129386T3 (pl) 2014-09-30

Family

ID=38330170

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08716883T PL2129386T3 (pl) 2007-03-28 2008-02-15 Probiotyki do zmniejszania ryzyka występowania otyłości

Country Status (16)

Country Link
US (1) US20100111915A1 (pl)
EP (2) EP1974734A1 (pl)
CN (1) CN101646445B (pl)
AU (1) AU2008231922B2 (pl)
BR (1) BRPI0809624A2 (pl)
CA (1) CA2677636A1 (pl)
CL (1) CL2008000928A1 (pl)
ES (1) ES2462747T5 (pl)
MX (1) MX2009008782A (pl)
MY (1) MY158816A (pl)
PL (1) PL2129386T3 (pl)
PT (1) PT2129386E (pl)
RU (1) RU2464994C2 (pl)
TW (1) TW200906427A (pl)
UA (1) UA96795C2 (pl)
WO (1) WO2008116700A1 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370729B (zh) * 2005-07-26 2012-08-29 三菱电机株式会社 乘客输送机
EP2011506A1 (en) 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
AU2009228716B2 (en) * 2008-03-28 2015-01-15 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
EP2459202A1 (en) * 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
WO2011034166A1 (ja) * 2009-09-17 2011-03-24 森永乳業株式会社 抗肥満剤、抗肥満用飲食品、耐糖能改善剤及び耐糖能改善用飲食品
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
FR2955774A1 (fr) * 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
NL2004200C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
EP2452572A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
ES2389547B1 (es) 2010-12-07 2013-08-08 Consejo Superior De Investigaciones Científicas (Csic) Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
EP2514435A1 (en) * 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
ES3005933T3 (en) 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
CA2841567A1 (en) * 2011-07-22 2013-01-31 Nestec S.A. Methods for reducing childhood obesity and for calculating childhood obesity risk
FI20116008A0 (fi) 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
FI126711B (fi) 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
KR20210013352A (ko) * 2012-09-20 2021-02-03 프로테라 인코포레이티드 비만 및 비만 관련 질환을 치료하기 위한 프로바이오틱 조성물 및 방법
CN108271917A (zh) 2013-03-08 2018-07-13 艾斯姆食品公司 大米蛋白补充剂
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
EP3091988B1 (en) 2014-01-10 2020-09-02 Société des Produits Nestlé S.A. Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring of overweight and/or obese mothers
US9980950B2 (en) 2014-01-10 2018-05-29 Nestec S.A. Maternal vitamin B6 administration for the prevention of increased adiposity, overweight or obesity in the offspring
MX2017001734A (es) * 2014-08-08 2017-04-27 Nestec Sa Mioinositol y probioticos y usos.
CN116270762A (zh) * 2014-08-08 2023-06-23 雀巢产品有限公司 肌肌醇和一种或多种益生菌以及它们的用途
MX374378B (es) * 2014-08-08 2025-03-06 Soc Des Produits Nestle S A Star Mioinositol y probioticos, y uso de estos.
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
USD796775S1 (en) 2015-09-09 2017-09-12 Intercontinental Great Brands Llc Confection
RU2740096C2 (ru) * 2015-12-11 2021-01-11 Элиментари Хелт Лимитед Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
BR112019028039A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia
EP3645024B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing fatty liver disease
AU2018414925B2 (en) * 2018-03-23 2023-05-04 Morinaga Milk Industry Co., Ltd. Composition for promoting the secretion of FGF21
WO2019180965A1 (ja) 2018-03-23 2019-09-26 森永乳業株式会社 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
KR102156399B1 (ko) * 2018-04-11 2020-09-16 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
CA3108735A1 (en) 2018-09-06 2020-03-12 Frieslandcampina Nederland B.V. Bifidogenic hypoallergenic gos compositions and methods for providing the same involving beta-galactosidase from a strain of lactobacillus delbrueckii ssp bulgaricus
CN109593678B (zh) * 2018-12-25 2020-11-10 嘉兴益诺康生物科技有限公司 长双歧杆菌yh295及其在制备降低腹型肥胖风险产品中的应用
CN111374256A (zh) * 2018-12-29 2020-07-07 内蒙古蒙牛乳业（集团）股份有限公司 益生菌组合物及其用途、食品和药品
CN114745969A (zh) * 2019-12-05 2022-07-12 N·V·努特里奇亚 用于改善超重和肥胖母亲所生的婴儿出生后生长的具有特殊脂质结构的婴儿配方物
EP4081225A1 (en) 2019-12-27 2022-11-02 Biopolis, S.L. Uses of lipoteichoic acid from bifidobacteria

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) † 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
FI110668B (fi) † 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
JP4108613B2 (ja) * 2002-04-12 2008-06-25 チェビジェン・インコーポレイテッド 共役リノール酸を生産する新規の菌主、これを含有するカプセル剤及びその製造方法
CN1457654A (zh) * 2003-06-04 2003-11-26 周霞轩 蒲公英儿童植物奶及制配与工艺
EP1638415B1 (en) † 2003-06-23 2010-12-15 Nestec S.A. Infant or follow-on formula
ES2326481T3 (es) * 2003-06-23 2009-10-13 Nestec S.A. Formula para recien nacidos o formula de continuacion.
US7001756B1 (en) † 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
CN100396770C (zh) † 2004-03-19 2008-06-25 景岳生物科技股份有限公司 新的微生物鼠李糖乳杆菌gm-020及其治疗肥胖的用途
KR100686557B1 (ko) † 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
DE602004015169D1 (de) * 2004-11-26 2008-08-28 Nutricia Nv Kleinkindernahrung mit proteasehemmer
WO2006091103A2 (en) * 2005-02-28 2006-08-31 N.V. Nutricia Nutritional composition with probiotics
EP1926395A1 (en) † 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
US7303745B2 (en) † 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233752A1 (en) † 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture

Also Published As

Publication number Publication date
RU2464994C2 (ru) 2012-10-27
CA2677636A1 (en) 2008-10-02
AU2008231922B2 (en) 2013-08-01
PT2129386E (pt) 2014-04-29
CN101646445A (zh) 2010-02-10
UA96795C2 (ru) 2011-12-12
ES2462747T5 (es) 2022-09-27
ES2462747T3 (es) 2014-05-26
MX2009008782A (es) 2009-08-24
RU2009139665A (ru) 2011-05-10
BRPI0809624A2 (pt) 2014-09-23
EP2129386B1 (en) 2014-04-16
US20100111915A1 (en) 2010-05-06
CL2008000928A1 (es) 2009-08-07
MY158816A (en) 2016-11-15
EP2129386B2 (en) 2022-05-18
WO2008116700A1 (en) 2008-10-02
EP1974734A1 (en) 2008-10-01
CN101646445B (zh) 2014-01-08
AU2008231922A1 (en) 2008-10-02
TW200906427A (en) 2009-02-16
EP2129386A1 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
PT2129386E (pt) Probióticos para a redução do risco de obesidade
GB2467974B (en) Spinal Orthosis
SI2405869T1 (sl) Zdravljenje debelosti
HUE059796T2 (hu) PSMA-t célzó vegyületek és alkalmazásaik
ZA200907539B (en) Reduction of risk of diarrhoea
GB0718597D0 (en) Urinal apparatus
EP2389388A4 (en) TREATMENT OF OBESITY
PL2222314T3 (pl) Zastosowanie i sposoby uzyskania rozluźnienia oskrzeli
GB0724883D0 (en) Ramp
IL200614A0 (en) Spout
IL205543A0 (en) Catenate for immunostimulation
PL382912A1 (pl) Sposób otrzymywania kalcypotriolu
EP2252306A4 (en) NEW USE OF PROBIOTICS
GB0723100D0 (en) Treatment of HFnEF
GB0718192D0 (en) Mooring aid
GB201114396D0 (en) Location of basesation
GB0719938D0 (en) All-in-one bedcover
GB0911709D0 (en) Stoma bridge
GB0806904D0 (en) Appetite control aid
GB0705414D0 (en) Shaped popcorn
HU0800058D0 (en) Pharmaceutical combination for reducing obesity
GB0705204D0 (en) Uses of (S)-clenbuterol
GB0813310D0 (en) Treatment of obesity
GB2450151B (en) Kiln
GB0711131D0 (en) Lining means